Lisa M Ooms

9PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologySolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2026
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling.

|Dec 17, 2025
Non-redundant roles of the phosphoinositide phosphatases PTEN and PIPP in PI3K/AKT signaling in breast cancer.

Lisa M Ooms, Daniel T Ferguson, Samuel J Rodgers

|Jul 20, 2023
The mechanisms of class 1A PI3K and Wnt/β-catenin coupled signaling in breast cancer.

Samuel J Rodgers, Christina A Mitchell, Lisa M Ooms

|Mar 29, 2023
Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models.

Maria Lambouras, Charlotte Roelofs, Melrine Pereira

|Jan 08, 2023
The FDA-Approved Drug Pyrvinium Selectively Targets ER+ Breast Cancer Cells with High INPP4B Expression.

Samuel J Rodgers, Lisa M Ooms, Christina A Mitchell

|Oct 07, 2021
A late endosome signaling hub that couples PI3Kα and WNT/β-catenin signaling in breast cancer.

Samuel J Rodgers, Sabryn A Hamila, Christina A Mitchell

Pageof 2

Frequent Collaborators

4 joint publications

Christina A Mitchell

3 joint publications

Samuel J Rodgers

3 joint publications

Catriona A McLean

3 joint publications

Antonella Papa